Leigh Zawel, See Remarks at Cullinan Oncology, Inc. (CGEM), sold 52,630 shares at $27.34 ($1.4M) on 2021-08-10, disclosed to the SEC on 2021-08-26.
Open-market sale of $1.4M CGEM by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.52 | 19,504 | $517K | 36.7% |
| 2 | $26.52 | 19,504 | $517K | 36.7% |
| 3 | $27.11 | 1,700 | $46K | 3.3% |
| 4 | $26.50 | 1,906 | $51K | 3.6% |
| 5 | $27.34 | 3,191 | $87K | 6.2% |
| 6 | $27.34 | 3,191 |
| $87K |
| 6.2% |
| 7 | $28.49 | 1,817 | $52K | 3.7% |
| 8 | $28.49 | 1,817 | $52K | 3.7% |
| Total | $26.77 avg | 52,630 | $1.4M | 100% |
| Filing → |
| CGEM | SELL | 2021-09-21 | $376K | — | Filing → |
| CGEM | SELL | 2021-09-08 | $1.6M | — | Filing → |
| CGEM | SELL | 2021-08-26 | $815K | — | Filing → |